NewAmsterdam Pharma Company NV Ordinary Shares

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$20.15
Previous Close
$20.12
Day Range
$19.91-$20.64
52W Range
$8.90-$26.35
Market Cap
$2.2B
Shares Short
718,042

Financials

See more
Revenue (12 Mos)
$33.5M
Revenue Growth (YoY)
889.8%
Gross Profit (12 Mos)
$0
Diluted EPS
-$2.21

News

See more

Yahoo Finance • 3 months ago

NewAmsterdam Pharma Second Quarter 2024 Earnings: Beats Expectations

Yahoo Finance • 6 months ago

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

Yahoo Finance • 7 months ago

NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease

Yahoo Finance • last year

Forbion co-leads €129 million Series A financing of VectorY, one of the largest private biotech financings in Europe in 2023

About

CEO
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Address
Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
62